IL116769A - Purion-6-On-Transformed Compositions 2.9, Preparation of Pharmaceutical Preparations Containing Them - Google Patents

Purion-6-On-Transformed Compositions 2.9, Preparation of Pharmaceutical Preparations Containing Them

Info

Publication number: IL116769A
Authority: IL; Israel
Prior art keywords: carbon atoms; chain; straight; branched alkyl; phenyl
Prior art date: 1995-01-19

Application number

IL11676996A

Other languages

English (en)

Hebrew (he)

Other versions

IL116769A0 (en

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-01-19

Filing date

1996-01-16

Publication date

1998-12-06

1996-01-16 Application filed by Bayer Ag filed Critical Bayer Ag

1996-05-14 Publication of IL116769A0 publication Critical patent/IL116769A0/xx

1998-12-06 Publication of IL116769A publication Critical patent/IL116769A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IL11676996A 1995-01-19 1996-01-16 Purion-6-On-Transformed Compositions 2.9, Preparation of Pharmaceutical Preparations Containing Them IL116769A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19501482A DE19501482A1 (de)	1995-01-19	1995-01-19	2,9-disubstituierte Purin-6-one

Publications (2)

Publication Number	Publication Date
IL116769A0 IL116769A0 (en)	1996-05-14
IL116769A true IL116769A (en)	1998-12-06

Family

ID=7751830

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11676996A IL116769A (en)	1995-01-19	1996-01-16	Purion-6-On-Transformed Compositions 2.9, Preparation of Pharmaceutical Preparations Containing Them

Country Status (31)

Country	Link
US (1)	US5861404A (es)
EP (1)	EP0722944A1 (es)
JP (1)	JPH08231545A (es)
KR (1)	KR960029334A (es)
CN (1)	CN1135485A (es)
AR (1)	AR002953A1 (es)
AU (1)	AU4097996A (es)
BG (1)	BG61728B1 (es)
BR (1)	BR9600147A (es)
CA (1)	CA2167353A1 (es)
CO (1)	CO4700523A1 (es)
CZ (1)	CZ16696A3 (es)
DE (1)	DE19501482A1 (es)
EE (1)	EE9600018A (es)
FI (1)	FI960225L (es)
HR (1)	HRP960007A2 (es)
HU (1)	HUP9600106A3 (es)
IL (1)	IL116769A (es)
MA (1)	MA23778A1 (es)
NO (1)	NO960223L (es)
NZ (1)	NZ280830A (es)
PE (1)	PE64996A1 (es)
PL (1)	PL312354A1 (es)
SG (1)	SG50401A1 (es)
SK (1)	SK8096A3 (es)
SV (1)	SV1996000006A (es)
TN (2)	TNSN96007A1 (es)
TR (1)	TR199600028A2 (es)
TW (1)	TW314519B (es)
YU (1)	YU1396A (es)
ZA (1)	ZA96398B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19529102A1 (de) *	1995-08-08	1997-02-13	Kummer Horst Dieter	Verwendung von PDE-Inhibitoren bei der Behandlung von Harnblasenerkrankungen
US5824669A (en)	1996-03-22	1998-10-20	Nitromed, Inc.	Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
USRE37234E1 (en)	1996-11-01	2001-06-19	Nitromed, Inc.	Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
US5958926A (en)	1996-11-01	1999-09-28	Nitromed, Inc.	Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
WO1999003858A1 (fr) *	1997-07-15	1999-01-28	Japan Energy Corporation	Derives purine et leur application medicinale
CA2309350C (en) *	1997-11-12	2007-04-03	Mitsubishi Chemical Corporation	Purine derivatives and medicaments comprising the same as active ingredient
USRE39112E1 (en) *	1998-01-05	2006-05-30	Eisai Co., Ltd.	Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes
US6124303A (en) *	1998-09-11	2000-09-26	Cell Pathways, Inc.	Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
US6268372B1 (en)	1998-09-11	2001-07-31	Cell Pathways, Inc.	Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
US6660745B1 (en) *	1999-05-11	2003-12-09	Mitsubishi Chemical Corporation	Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof
GB9924020D0 (en)	1999-10-11	1999-12-15	Pfizer Ltd	Pharmaceutically active compounds
ATE552013T1 (de) *	2000-09-06	2012-04-15	Mitsubishi Tanabe Pharma Corp	Zubereitungen zur oralen anwendung
KR100750554B1 (ko) *	2001-02-15	2007-08-20	다나베 세이야꾸 가부시키가이샤	구강 내 속붕괴성 정제
US6479493B1 (en)	2001-08-23	2002-11-12	Cell Pathways, Inc.	Methods for treatment of type I diabetes
US7893101B2 (en)	2002-03-20	2011-02-22	Celgene Corporation	Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
US7276529B2 (en)	2002-03-20	2007-10-02	Celgene Corporation	Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US7208516B2 (en)	2002-03-20	2007-04-24	Celgene Corporation	Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US6962940B2 (en)	2002-03-20	2005-11-08	Celgene Corporation	(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
CN102742513A (zh) *	2012-07-17	2012-10-24	南京熊猫机电制造有限公司	一种喂食栏装置
US10300042B2 (en)	2014-06-23	2019-05-28	Celgene Corporation	Apremilast for the treatment of a liver disease or a liver function abnormality
US11198699B2 (en)	2019-04-02	2021-12-14	Aligos Therapeutics, Inc.	Compounds targeting PRMT5
JP7385467B2 (ja) *	2019-12-26	2023-11-22	キッセイ薬品工業株式会社	ヒポキサンチン化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4451478A (en) *	1982-03-12	1984-05-29	Newport Pharmaceuticals International, Inc.	Imidazole compounds
IL76546A (en) *	1984-10-12	1988-12-30	Warner Lambert Co	9-(heteroarylalkyl)-6-purine(thi)one derivatives,their preparation and pharmaceutical compositions containing them
GB9213623D0 (en) *	1992-06-26	1992-08-12	Pfizer Ltd	Therapeutic agents

1995
- 1995-01-19 DE DE19501482A patent/DE19501482A1/de not_active Withdrawn
- 1995-12-27 TW TW084113907A patent/TW314519B/zh active
1996
- 1996-01-08 EP EP96100156A patent/EP0722944A1/de not_active Withdrawn
- 1996-01-08 HR HR19501482.0A patent/HRP960007A2/hr not_active Application Discontinuation
- 1996-01-12 US US08/587,321 patent/US5861404A/en not_active Expired - Fee Related
- 1996-01-12 YU YU1396A patent/YU1396A/sh unknown
- 1996-01-15 TR TR96/00028A patent/TR199600028A2/xx unknown
- 1996-01-15 AU AU40979/96A patent/AU4097996A/en not_active Abandoned
- 1996-01-16 NZ NZ280830A patent/NZ280830A/en unknown
- 1996-01-16 CA CA002167353A patent/CA2167353A1/en not_active Abandoned
- 1996-01-16 IL IL11676996A patent/IL116769A/en not_active IP Right Cessation
- 1996-01-17 SG SG1996000260A patent/SG50401A1/en unknown
- 1996-01-17 FI FI960225A patent/FI960225L/fi unknown
- 1996-01-17 TN TNTNSN96007A patent/TNSN96007A1/fr unknown
- 1996-01-17 PL PL96312354A patent/PL312354A1/xx unknown
- 1996-01-17 TN TNTNSN96006A patent/TNSN96006A1/fr unknown
- 1996-01-18 ZA ZA96398A patent/ZA96398B/xx unknown
- 1996-01-18 JP JP8023473A patent/JPH08231545A/ja active Pending
- 1996-01-18 CZ CZ96166A patent/CZ16696A3/cs unknown
- 1996-01-18 BR BR9600147A patent/BR9600147A/pt active Search and Examination
- 1996-01-18 NO NO960223A patent/NO960223L/no unknown
- 1996-01-18 HU HU9600106A patent/HUP9600106A3/hu unknown
- 1996-01-18 BG BG100292A patent/BG61728B1/bg unknown
- 1996-01-18 EE EE9600018A patent/EE9600018A/xx unknown
- 1996-01-18 KR KR1019960001002A patent/KR960029334A/ko not_active Application Discontinuation
- 1996-01-18 SK SK80-96A patent/SK8096A3/sk unknown
- 1996-01-18 MA MA24133A patent/MA23778A1/fr unknown
- 1996-01-19 PE PE1996000043A patent/PE64996A1/es not_active Application Discontinuation
- 1996-01-19 CN CN96101917A patent/CN1135485A/zh active Pending
- 1996-01-19 CO CO96002169A patent/CO4700523A1/es unknown
- 1996-01-19 SV SV1996000006A patent/SV1996000006A/es unknown
- 1996-01-19 AR ARP960101088A patent/AR002953A1/es unknown

Also Published As

Publication number	Publication date
HUP9600106A2 (en)	1997-05-28
AU4097996A (en)	1996-07-25
BG61728B1 (bg)	1998-04-30
CZ16696A3 (en)	1996-08-14
YU1396A (sh)	1999-03-04
HRP960007A2 (en)	1998-02-28
CN1135485A (zh)	1996-11-13
US5861404A (en)	1999-01-19
SK8096A3 (en)	1996-08-07
PL312354A1 (en)	1996-07-22
NZ280830A (en)	1998-04-27
ZA96398B (en)	1996-08-28
EP0722944A1 (de)	1996-07-24
TW314519B (es)	1997-09-01
CO4700523A1 (es)	1998-12-29
AR002953A1 (es)	1998-05-27
EE9600018A (et)	1996-08-15
FI960225L (fi)	1996-07-20
TR199600028A2 (tr)	1996-08-21
SG50401A1 (en)	1998-07-20
KR960029334A (ko)	1996-08-17
BR9600147A (pt)	1998-01-06
SV1996000006A (es)	1996-10-29
TNSN96006A1 (fr)	2005-03-15
JPH08231545A (ja)	1996-09-10
CA2167353A1 (en)	1996-07-20
HU9600106D0 (en)	1996-03-28
DE19501482A1 (de)	1996-07-25
MA23778A1 (fr)	1996-10-01
FI960225A0 (fi)	1996-01-17
IL116769A0 (en)	1996-05-14
BG100292A (bg)	1996-07-31
TNSN96007A1 (fr)	2005-03-15
NO960223L (no)	1996-07-22
HUP9600106A3 (en)	1998-04-28
PE64996A1 (es)	1997-03-09
NO960223D0 (no)	1996-01-18

Publication	Publication Date	Title
AU704102B2 (en)	1999-04-15	2,8-disubstituted quinazolinones
IL116769A (en)	1998-12-06	Purion-6-On-Transformed Compositions 2.9, Preparation of Pharmaceutical Preparations Containing Them
US6174884B1 (en)	2001-01-16	1,5-dihydro-pyrazolo[34-D]-pyrimidinone derivatives
AU720305B2 (en)	2000-05-25	Purin-6-one derivatives
US6458796B1 (en)	2002-10-01	Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one
KR101491938B1 (ko)	2015-02-10	Ｉｐ 수용체 효능제 헤테로시클릭 화합물
US5981527A (en)	1999-11-09	Cyclic GMP-specific phosphodiesterase inhibitors
EP1309594B1 (fr)	2004-12-15	Derives de benzimidazole, leur preparation et leur application en therapeutique
US5866571A (en)	1999-02-02	9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones
JP2672290B2 (ja)	1997-11-05	新規なピロロカルバゾール類
HU208824B (en)	1994-01-28	Process for the production of selestive adenozine antagonistic xantine derivatives and medical preparations containing them as active agents
US6949652B2 (en)	2005-09-27	Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A]pyridine
WO2008031788A1 (en)	2008-03-20	Aminoazepine derivatives as highly efficient inhibitors of the inducible nitric oxide synthase

Legal Events

Date	Code	Title
1999-06-20	FF	Patent granted
1999-10-28	KB	Patent renewed
2002-09-12	MM9K	Patent not in force due to non-payment of renewal fees